Scholars Central

ArticlePublished 17 Sep 2025

A meta-analysis of management of elevated intracranial pressure in traumatic brain injury: Hypertonic saline vs. Mannitol

Authors: Mohamed S. Imam, Abdullah Mahammed Jaber Almalki, Faisal Saleh Saeed Alswat, Atheer Zayed Safar Alotaibi, Nardeen Awad Saed Algethami, Shoog Hameed Mohammad Altalhi, Amal Ali Mohammed Alshehri, Rahaf Naif Alhashbari, Randa Matuq Aljuaid, Wejdan Muhsen Alsufyane, Ibtisam Eidhah Althubyani

Modern Phytomorphology

Issue special-3001025 · Pages S41–S52

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background and objectives: We conducted a meta-analysis to evaluate the comparative efficacy of hypertonic saline (HS) versus mannitol in the management of elevated Intracranial Pressure (ICP) among patients with Traumatic Brain Injury (TBI). Materials and methods: A systematic literature search up to February 2025 identified 18 studies including 1,828 patients with TBI. The analysis compared the effects of HS and mannitol on elevated ICP control. Odds Ratios (ORs) and Mean Differences (MDs) with 95% Confidence Intervals (CIs) were calculated using dichotomous or continuous approaches, applying either fixed- or random-effects models. Results: Compared with mannitol, HS was associated with a significantly lower treatment failure rate (OR 0.38; 95% CI 0.15-0.98; p=0.04), higher cerebral perfusion pressure at 30-60 minutes post-infusion (MD 5.25; 95% CI 3.59-6.91; p<0.001), and lower ICP at 30-60 minutes (MD-1.12; 95% CI -2.11 to -0.12; p=0.03). However, HS did not significantly affect mortality, functional outcomes, cerebral perfusion pressure at 90-120 minutes, ICP at 90-120 minutes, or the daily duration of elevated ICP. Conclusion: In patients with TBI, HS was superior to mannitol in reducing treatment failure, improving cerebral perfusion pressure, and lowering ICP within 30-60 minutes of administration. However, no significant differences were observed in mortality, long-term functional outcomes, or ICP control beyond 90 minutes. These findings suggest HS may offer short-term hemodynamic advantages over mannitol, but larger, high-quality trials are required to confirm its long-term clinical benefit.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalModern Phytomorphology
  • SubjectAnaesthesia & Pain
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Mohamed S. Imam”
  • BylineArticles whose byline prints “Abdullah Mahammed Jaber Almalki”
  • BylineArticles whose byline prints “Faisal Saleh Saeed Alswat”
  • BylineArticles whose byline prints “Atheer Zayed Safar Alotaibi”
  • BylineArticles whose byline prints “Nardeen Awad Saed Algethami”
  • BylineArticles whose byline prints “Shoog Hameed Mohammad Altalhi”
  • BylineArticles whose byline prints “Amal Ali Mohammed Alshehri”
  • BylineArticles whose byline prints “Rahaf Naif Alhashbari”